Fainardi E. , Castellazzi M. , Bellini T. , Manfrinato MC , Baldi E. , Casetta I. et al. Cerebrospinal fluid and serum levels and intrathecal production ofl active matrix metalloproteinase-9 (MMP-9) as markers ofl disease activity in patients with multiple sclerosis . Mult Scler2006; 12: 294-301 .
Mannello F. , Luchetti F. , Canonico B. , Papa S.Eflflect ofl anticoagulants and cell separation media as preanalytical determinants on zymographic analysis ofl plasma matrix metalloproteinases . Clin Chem2003; 49: 1956-57 .
4.
Gerlach RF , Uzuelli JA , Souza-Tarla CD , Tanus-Santos JEEflflect ofl anticoagulants on plasma matrix metalloproteinase (MMP)-2 and MMP-9 activities . Anal Biochem2005; 344: 147-49 .
5.
Rouy D. , Ernens I. , Jeanty C. , Wagner DRPlasma storage at -80 degrees C does not protect matrix metalloproteinase-9 flrom degradation . Anal Biochem2005; 338: 294-98 .
6.
Souza-Tarla CD , Uzuelli JA , Machado AA , Gerlach RF , Tanus-Santos JEMethodological issues aflflecting the determination ofl plasma matrix metalloproteinase (MMP)-2 and MMP-9 activities . Clin Biochem2005; 38: 410-14 .
7.
Sheu JR , Fong TH , Liu CM , Shen MY , Chen TL , Chang Y. et al. Expression ofl matrix metalloproteinase-9 in human platelets: regulation ofl platelet activation in in vitro and in in vivo studies . Br J Pharmacol2004; 143: 193-201 .
8.
Sawicki G. , Salas E. , Murat J. , Miszta-Lane H. , Radomski MWRelease ofl gelatinase A during platelets activation mediates aggregation . Nature1997; 386: 616-19 .
9.
Freedman MS , Thompson EJ , Deisenhammer F. , Giovannoni G. , Grimsley G. , Keir G. et al. Recommended standard ofl cerebrospinal fluid analysis in the diagnosis ofl multiple sclerosis. A Consensus Statement . Arch Neurol2005; 62: 865-70 .
10.
Verspaget HW , Kuyvenhoven JP , van Hock B.Preanalytical conditions and circulating matrix metalloproteinases . Transplantation2005; 79: 745-46 .